Bioventix PLC (LON:BVXP – Get Free Report) insider Bruce Hiscock bought 119 shares of the company’s stock in a transaction that occurred on Monday, October 27th. The shares were bought at an average price of GBX 2,009 per share, for a total transaction of £2,390.71.
Bioventix Stock Up 2.7%
Shares of LON BVXP opened at GBX 1,900 on Friday. The business’s 50 day moving average price is GBX 2,389.21 and its two-hundred day moving average price is GBX 2,579.21. The company has a market cap of £99.28 million, a PE ratio of 12.83 and a beta of 0.35. Bioventix PLC has a twelve month low of GBX 1,750 and a twelve month high of GBX 4,000.
Bioventix (LON:BVXP – Get Free Report) last announced its quarterly earnings results on Monday, October 27th. The biotechnology company reported GBX 145.27 earnings per share for the quarter. Bioventix had a return on equity of 69.09% and a net margin of 59.51%. As a group, research analysts anticipate that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Featured Articles
- Five stocks we like better than Bioventix
- Stock Sentiment Analysis: How it Works
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- 3 Grocery Stocks That Are Proving They Are Still Essential
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- The 3 Best Blue-Chip Stocks to Buy Now
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
